$28.70
3.21[12.59%]
At close: Apr 26
$28.70
0[0.00%]
After Hours: 5:13PM EDT
PTC Therapeutics
(NASDAQ:PTCT)Latest News for PTC Therapeutics Stock (NASDAQ:PTCT)
PTC Therapeutics Stock (NASDAQ: PTCT)
Categories: All
Friday, April 26, 2024
Thursday, April 25, 2024
- PTC Therapeutics Reaffirms FY24 Financial Guidance; Total Revenues Of $600M-$680M, Est $606.63MBenzinga Newsdesk - 1 day ago
- PTC Therapeutics Says On Target To Achieve Remaining 2024 Clinical And Regulatory Milestones, Including Global Submissions For SepiapterinBenzinga Newsdesk - 1 day ago
- PTC Therapeutics Q1 2024 GAAP EPS $(1.20) Beats $(1.29) Estimate, Sales $210.118M Beat $169.703M EstimateBenzinga Newsdesk - 1 day ago
Friday, April 12, 2024
Thursday, March 28, 2024
Friday, March 08, 2024
Friday, March 01, 2024
- PTC Therapeutics shares are trading higher after the company reported Q4 financial results.Benzinga Newsdesk - Mar 1, 2024, 12:35PM
- Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On FridayAvi Kapoor - Mar 1, 2024, 11:18AM
- RBC Capital Maintains Sector Perform on PTC Therapeutics, Raises Price Target to $28Benzinga Newsdesk - Mar 1, 2024, 10:29AM
- Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $45 Price TargetBenzinga Newsdesk - Mar 1, 2024, 9:40AM
- TD Cowen Maintains Market Perform on PTC Therapeutics, Lowers Price Target to $30Benzinga Newsdesk - Mar 1, 2024, 8:44AM
Thursday, February 29, 2024
- PTC Therapeutics Sees FY24 Revenue $600M-$680M Est. Vs $612.290M Est.Benzinga Newsdesk - Feb 29, 2024, 4:40PM
- Recap: PTC Therapeutics Q4 EarningsBenzinga Insights - Feb 29, 2024, 4:25PM
- PTC Therapeutics Q4 2023 Adj EPS $(0.240) Misses $0.500 Estimate, Sales $307.056M Miss $321.294M EstimateBenzinga Newsdesk - Feb 29, 2024, 4:24PM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Friday, January 26, 2024
- Cantor Fitzgerald Maintains Overweight on PTC Therapeutics, Lowers Price Target to $45Benzinga Newsdesk - Jan 26, 2024, 12:42PM
- RBC Capital Maintains Sector Perform on PTC Therapeutics, Lowers Price Target to $22Benzinga Newsdesk - Jan 26, 2024, 10:29AM
- PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In EuropeVandana Singh - Jan 26, 2024, 9:00AM
- PTC Therapeutics shares are trading lower after the company announced the CHMP of the EMA issued a negative opinion following the re-examination procedure for the conditional marketing authorization of Translarna.Benzinga Newsdesk - Jan 26, 2024, 8:39AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Jan 26, 2024, 8:05AM
Thursday, January 25, 2024
- PTC Therapeutics shares are trading lower after the company announced the CHMP of the EMA issued a negative opinion following the re-examination procedure for the conditional marketing authorization of Translarna.Benzinga Newsdesk - Jan 25, 2024, 4:43PM
- CHMP Issues Negative Opinion For Renewal Of Conditional Marketing Authorization For Translarna Following Re-Examination Procedure; Per European Regulations, The European Commission Has 67 Days To Adopt The OpinionBenzinga Newsdesk - Jan 25, 2024, 4:36PM
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jan 25, 2024, 4:31PM
Monday, January 08, 2024
Tuesday, December 19, 2023
Monday, December 18, 2023
Monday, November 20, 2023
Friday, October 27, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Oct 27, 2023, 1:30PM
- Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?Vandana Singh - Oct 27, 2023, 1:00PM
- Morgan Stanley Maintains Equal-Weight on PTC Therapeutics, Lowers Price Target to $28Benzinga Newsdesk - Oct 27, 2023, 9:40AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Oct 27, 2023, 9:05AM
- PTC Therapeutics shares are trading lower after the company reported worse-than-expected Q3 financial results.Benzinga Newsdesk - Oct 27, 2023, 8:38AM
- Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For FridayLisa Levin - Oct 27, 2023, 8:06AM
- Barclays Maintains Equal-Weight on PTC Therapeutics, Lowers Price Target to $25Benzinga Newsdesk - Oct 27, 2023, 7:36AM
- Citigroup Downgrades PTC Therapeutics to Sell, Lowers Price Target to $17Benzinga Newsdesk - Oct 27, 2023, 6:43AM
Thursday, October 26, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Oct 26, 2023, 5:31PM
- PTC Therapeutics Q3 2023 EPS $(1.76) Misses $(1.17) Estimate, Sales $196.58M Miss $210.19M EstimateBenzinga Newsdesk - Oct 26, 2023, 4:50PM
- Earnings Scheduled For October 26, 2023Benzinga Insights - Oct 26, 2023, 7:20AM
Wednesday, October 25, 2023
Thursday, October 19, 2023
- Nasdaq Falls 100 Points; AT&T Posts Upbeat EarningsLisa Levin - Oct 19, 2023, 2:37PM
- Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Oct 19, 2023, 1:52PM
- PTC Therapeutics shares are trading higher after the company announced an agreement with Royalty Pharma to monetize up to $1.5 billion of the Evrysdi Royalty StreamBenzinga Newsdesk - Oct 19, 2023, 1:26PM
- AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On ThursdayLisa Levin - Oct 19, 2023, 9:56AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Oct 19, 2023, 9:06AM
- PTC Therapeutics Announced An Agreement With Royalty Pharma To Monetize Up To $1.5B Of The Evrysdi Royalty Stream. Under The Agreement, Royalty Pharma Acquires Additional Royalties On Evrysdi For $1B UpfrontBenzinga Newsdesk - Oct 19, 2023, 8:07AM